Clinical Policy: Attention Deficit Hyperactivity Disorder Assessment and Treatment
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.BH.124 alerts
Get alerted when Policy CP.BH.124 changes without checking for updates manually.
Monitor payer policy activity
Defines medically necessary assessment and treatment services for Attention Deficit Hyperactivity Disorder (ADHD) and lists assessment/treatment interventions considered insufficient evidence or not medically necessary for members of Centene-affiliated health plans.
Clarified that collection of collateral information and toxicology screen are included in Section I.A.
Clarified that ongoing assessment and application of standardized scales to assess treatment benefit are included in Section I.B.
Removed specific CPT codes (e.g., 78607, 95827, 97127) and added multiple CPT codes including many EEG/evoked potential codes and cognitive therapy CPTs (e.g., 95705-95726 series, 97129, 97130); added HCPCS G0176.
Specified that ECG (CPT 93000/93005/93010) is not medically necessary when billed with a sole diagnosis of ADHD unless clinically indicated.
Assessment of serum lipid profiles was added to the not medically necessary list with associated CPT codes (80061, 83718, 83719, 82721, 83722, 84475) when billed with a sole diagnosis of ADHD.
Policy statement clarifying interventions that are strictly educational in nature are not medically necessary was added.
Video game–based interventions (e.g., EndeavorRX, AKL-T01) were added to the list of interventions addressed in the policy (not medically necessary table references updated).
Coverage Criteria and Policy Scope
Medical necessity and exclusions overview
Covered when provided as part of assessment and treatment for ADHD and meet clinical indication:
Documentation of these assessment elements is required to support medical necessity.
Ongoing standardized assessment is expected to document clinical benefit and guide continued therapy.
See the full policy coding and not‑medically‑necessary tables for complete lists.
These items are detailed in Section II of the policy and may be excluded or require additional justification.
Medical necessity clarifications and insufficient-evidence list
Policy statements and changes regarding medical necessity and insufficient evidence
Updated in Section I.A and I.B to reflect assessment and monitoring expectations.
Terminology change made during annual review; does not itself alter clinical criteria.
Reflects alignment with AAP 2019 guideline updates and subsequent annual reviews.
Highlighted coverage updates
Policy updates and coverage stance highlights from revisions
Documentation must support the clinical indication for ECG when billed.
Added in coding updates; may require prior authorization or additional diagnosis codes.
These services are excluded from medical coverage per policy statement III.
These interventions are named among device/behavioral digital therapeutics in recent updates.
Operational coding changes are substantive and may affect claims processing.
Interventions that are strictly educational in nature are excluded from coverage. Examples explicitly listed in the policy include classroom environmental manipulation and academic skills training. These are not considered medical interventions and therefore are not medically necessary under this policy.
Several CPT/HCPCS and laboratory codes are identified as not medically necessary when billed with a sole diagnosis of ADHD. Examples called out in the policy include HCPCS G0176 (activity therapy), HCPCS P2031 (hair analysis), and HCPCS S8040 (topographic brain mapping). The policy also added ECG CPTs (93000, 93005, 93010) and serum lipid/laboratory CPTs (eg, 80061, 83718, 83719, 82721, 83722, 84475) to the not medically necessary list when billed with only an ADHD diagnosis; these codes require appropriate additional clinical indication or supporting diagnoses to be considered medically necessary.
The policy reiterates that interventions that are strictly educational in nature (for example, classroom environmental manipulation and academic skills training) are not medically necessary because they are not medical interventions. Providers should not bill these services as medically necessary treatments for ADHD.
The policy lists numerous assessment tests and treatment modalities that are considered to have insufficient evidence to support use for ADHD or are not medically necessary. Assessment examples include actigraphy, computerized EEG/qEEG/NEBA, event-related potentials, hair analysis, pharmacogenetic tools, neuroimaging (CT, MRI, PET, SPECT), otoacoustic emissions when no hearing loss is present, and various laboratory measures. Treatment and adjunctive examples include EEG biofeedback/neurofeedback, transcranial magnetic stimulation/cranial electric stimulation (TMS/eTNS), cannabinoids, chiropractic manipulation, cognitive training/computerized working memory training, intensive behavioral intervention programs (ABA) in certain billing contexts, vision/optometric training, and video game–based therapeutic interventions (eg, EndeavorRx, AKL-T01). These items are listed as lacking sufficient evidence or are not medically necessary for ADHD per the policy.
When billed with a sole ADHD diagnosis, specific HCPCS and diagnosis codes are limited. The policy specifies HCPCS codes G0176, P2031, and S8040 as considered not medically necessary if submitted with only an ADHD ICD-10 code. Likewise, the ICD-10 codes F90.0–F90.9 (ADHD codes) billed as the only diagnosis do not, by themselves, support medical necessity for many listed procedures.
Providers should consult the policy’s full coding tables for exact code-by-code determinations of what is labeled not medically necessary when billed with a sole ADHD diagnosis. The document notes numerous CPT and HCPCS additions and removals across revisions (including ECG and lipid panel CPTs, ABA CPTs, and HCPCS G0176), and plan-specific prior authorization or clinical justification may be required when these codes are billed. Verify the current coding tables and plan rules before billing.
Procedure, HCPCS, and Diagnosis Codes
| 70450 | Computed tomography, head or brain; without contrast material. |
| 70460 | Computed tomography, head or brain; with contrast material(s). |
| 70470 | Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections. |
| 70496 | Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing. |
| 70544 | Magnetic resonance angiography, head; without contrast material(s). |
| 70545 | Magnetic resonance angiography, head; with contrast material(s). |
| 70546 | Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and further sequences. |
| 70551 | Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material. |
| 70552 | Magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s). |
| 70553 | Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences. |
| 84436 | Thyroxine; total. |
| 84439 | Thyroxine; free. |
| 84442 | Thyroxine binding globulin (TBG). |
| 84443 | Thyroid stimulating hormone (TSH). |
| 84445 | Thyroid stimulating immune globulins (TSI). |
| 84478 | Triglycerides. |
| 84481 | Triiodothyronine T3; free. |
| 84630 | Zinc. |
| 86001 | Allergen specific IgG quantitative or semiquantitative, each allergen. |
| 92065 | Orthoptic training performed by a physician or other qualified health care professional. |
| F90.0-F90.9 | Attention-deficit hyperactivity disorders (when billed as the only diagnosis do not support medical necessity for the listed procedures). |
| 78607 | CPT code removed |
| 95827 | CPT code removed |
| 97127 | CPT code removed |
| G0176 | HCPCS code added |
| 93000 | ECG - added to not medically necessary table when billed with sole ADHD diagnosis |
| 93005 | ECG - added to not medically necessary table when billed with sole ADHD diagnosis |
| 93010 | ECG - added to not medically necessary table when billed with sole ADHD diagnosis |
| 80061 | Serum lipid profile - added to not medically necessary table when billed with sole ADHD diagnosis |
| 83718 | Lipid testing - added to not medically necessary table when billed with sole ADHD diagnosis |
| 83719 | Lipid testing - added to not medically necessary table when billed with sole ADHD diagnosis |
| 82721 | Laboratory code added to not medically necessary table when billed with sole ADHD diagnosis |
| 83722 | Laboratory code added to not medically necessary table when billed with sole ADHD diagnosis |
| 84475 | Laboratory code added to not medically necessary table when billed with sole ADHD diagnosis |
| 70544 | CPT added to not medically necessary table |
| 70545 | CPT added to not medically necessary table |
| 70546 | CPT added to not medically necessary table |
| 95957 | CPT added to not medically necessary table |
| 97151 | CPT for ABA services added to not medically necessary table |
| 97152 | CPT for ABA services added to not medically necessary table |
| 97153 | CPT for ABA services added to not medically necessary table |
| 97154 | CPT for ABA services added to not medically necessary table |
| 97155 | CPT for ABA services added to not medically necessary table |
| 97156 | CPT for ABA services added to not medically necessary table |
Provider Documentation, Billing, and Authorization Guidance
Provider Action: Documentation, Billing Risk, and Prior Authorization
Providers: many CPT, HCPCS, and laboratory codes are designated as not medically necessary when billed with a sole diagnosis of ADHD (ICD-10 F90.0–F90.9). Billing these codes without supporting clinical documentation and additional relevant diagnoses may result in claim denials or requests for medical records. When ordering ECGs or serum lipid testing, document a clear clinical indication (see items). Verify that any newly added ABA or other CPT/HCPCS codes meet plan-specific prior authorization requirements before rendering services.
- Diagnosis-only denials: ICD-10 codes F90.0–F90.9 billed as the only diagnosis do not support medical necessity for the procedures listed in the not medically necessary tables.
- Not medically necessary when billed with sole ADHD diagnosis: Examples include many neuroimaging (e.g., CT/MRI/MRA/PET codes such as 70450–70470, 70544–70555, 70496, 78610), vestibular and audiology testing (e.g., 92540–92570 series), genetic and laboratory testing (e.g., 81171–81172, 81229, 80061, 82365, 82465, 82728, 82784, 82787, 83540, 83550, 83718–83722, 84436–84481), TMS and biofeedback (90867–90869, 90901), cognitive/vision training (92066, 92545–92548), ABA and intensive behavioral intervention CPTs (97151–97158) and HCPCS (G0176, P2031, S8040), plus numerous physical modality codes (e.g., 97010–97036). Refer to the policy code lists for the full enumerated codes.
- ECG and lipid panel coding guidance: CPT codes 93000, 93005, 93010 (ECG) and lipid panel codes such as 80061 and component lipid CPTs (e.g., 83718, 83719, 83721/83722, 82465, 84475/84478 series) have been added to the not medically necessary list when billed with a sole ADHD diagnosis — unless clinical indications and documentation support their necessity.
- ECG clinical indication documentation: ECGs should be performed only if clinically indicated (for example, personal or family history of cardiovascular disease, congenital heart disease, abnormal cardiac symptoms, or specific medication-related cardiac risk). When billing ECG CPTs, include documentation in the medical record that supports the clinical indication.
- Prior authorization: Several ABA and other CPT/HCPCS codes were recently added to the policy’s not medically necessary lists or code updates (e.g., 97151–97158, G0176). Providers must verify plan-specific prior authorization requirements for ABA and any newly added codes before providing services to avoid denials or nonpayment.
Permitted and Not-Supported Treatments
Pharmacotherapy / Behavioral modification
Ongoing assessment with standardized scales is expected to measure treatment benefit.
TMS
Codes present in coding tables; clinical coverage criteria for TMS are not provided in these cited chunks.
Cognitive rehabilitation/training
Codes may appear in coding tables but policy treats cognitive training as lacking sufficient evidence for routine ADHD treatment.
Video game–based interventions
Named examples included in II.B.39 and subsequent coding table updates.
Applied Behavior Analysis and Intensive Behavioral Intervention
ABA service coding notes
ABA/Intensive behavioral intervention coding and policy placement
Providers should verify plan‑specific prior authorization and clinical criteria for ABA services; coding updates across revisions may affect coverage determinations.
Key Terms and Definitions
Visit Limits and Service Restrictions
Clinical Background and Guidelines
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by persistent inattention and/or hyperactivity-impulsivity that is maladaptive and inconsistent with developmental level. Diagnosis is clinical and relies on a complete medical evaluation including history and physical, standardized interview per DSM-5 (patient/parent or patient interview where appropriate), and collection of collateral information (eg, Vanderbilt or Conners). Evidence-based treatments referenced in the policy include pharmacotherapy and behavioral modification, with attention to treating comorbid behavioral health or medical diagnoses and using ongoing standardized assessments to monitor treatment benefit.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.